Factors influencing route of administration for epoetin treatment among hemodialysis patients in the United States.

Thamer, Mae; Zhang, Yi; Kaufman, James; Stefanik, Kevin; Cotter, Dennis J

Thamer, Mae; Zhang, Yi; Kaufman, James; Stefanik, Kevin; Cotter, Dennis J.

Affiliation

Thamer M; Medical Technology and Practice Patterns Institute, Bethesda, MD, USA.

Am J Kidney Dis ; 48(1): 77-87, 2006 Jul.

Article in En | MEDLINE | ID: mdl-16797389

Subject(s)

Erythropoietin/administration & dosage; Erythropoietin/economics; Hematinics/administration & dosage; Hematinics/economics; Renal Dialysis; Adult; Aged; Cohort Studies; Cost Savings; Decision Making; Drug Prescriptions/economics; Epoetin Alfa; Erythropoietin/therapeutic use; Female; Hematinics/therapeutic use; Humans; Injections, Subcutaneous; Male; Medicare/economics; Middle Aged; Ownership; Physician Incentive Plans; Practice Patterns, Physicians'/statistics & numerical data; Recombinant Proteins; United States

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Erythropoietin / Renal Dialysis / Hematinics Type of study: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Am J Kidney Dis Year: 2006 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links